Mylanta Extra Antacid

Mylanta is a globally recognized over-the-counter medication used primarily for the relief of heartburn, acid indigestion, and gas. The brand was originally developed in the United States by the Stuart Pharmaceutical Company. Over the decades, the rights to the brand have shifted through various pharmaceutical giants, including Johnson & Johnson and Merck.

In specific regional markets like Argentina, the brand is commercialized and manufactured under license by local pharmaceutical leaders. The specific product shown in the image, Mylanta Extra, is manufactured in Argentina by Laboratorio Elea Phoenix S.A., which holds the commercial rights for the brand within the Argentine territory. This local production ensures that the pharmaceutical standards meet regional regulatory requirements while maintaining the global brand identity.

Worldwide, the ownership of the Mylanta brand is fragmented. While Infirst Healthcare owns the rights for the US market (under license from McNeil Consumer Healthcare, a subsidiary of Kenvue/Johnson & Johnson), in South American markets like Argentina, the brand operates under the stewardship of local entities like Laboratorio Elea, which is a prominent player in the regional healthcare industry.